SHANGHAI – Another month, another announcement for Lee's Pharmaceuticals Ltd., of Hong Kong, as it has been slowly but surely building a successful biotech business and developing and commercializing products for the China market.
SHANGHAI – Newcomer Ark Biosciences Inc., of Shanghai, has announced its first deal with the acquisition of global rights to Roche AG's respiratory syncytial virus (RSV) drug candidate, AK0529. RSV is one of the most infectious human viruses and the number one cause of death and hospitalization for children younger than 5. There is currently no vaccine or therapeutic drug for RSV infection.
SHANGHAI – Chia-Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ), of Jiangsu, has taken steps to bring a biosimilar version of Pfizer Inc.'s Xyntha, a recombinant human coagulation factor VIII (rhFVIII), to the clinic and moves a step closer to providing a much-needed, affordable treatment for China's hemophilia A sufferers.
SHANGHAI – Chia-Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ), of Jiangsu, has taken steps to bring a biosimilar version of Pfizer Inc.'s Xyntha, a recombinant human coagulation factor VIII (rhFVIII), to the clinic and moves a step closer to providing a much-needed, affordable treatment for China's hemophilia A sufferers.
SHANGHAI – Newcomer Ark Biosciences Inc., of Shanghai, has announced its first deal with the acquisition of global rights to Roche AG's respiratory syncytial virus (RSV) drug candidate, AK0529.
SHANGHAI – A new licensing deal is giving Taiwan’s Taigen Biotechnology Co. inroads into the large Russian market just as the parent company’s shares started trading in Taiwan.
SHANGHAI – For some pharma executives parachuting into China it may come as a surprise to learn that the best way to get rid of a corrupt employee is to pay them off.
SHANGHAI – Last week the CFDA put out a circular to warn Chinese consumers about the dangers of buying cancer medicines online, in particular drugs that claim to be Iressa (gefitinib) imported from India.
SHANGHAI – While Wuxi Apptec may be best known for its biologic manufacturing capabilities, it could be overlooked that the firm has ratcheted up its capabilities in clinical drug development as well.
SHANGHAI – China's distribution sector took a big step toward consolidation with the announcement that Sinopharm Group Co. Ltd. and Shanghai Fosun Group Co. Ltd. would form a joint venture (JV) to create what promises to be the first nationwide drug and medical device network.
